Vanderbilt University Medical Center nephrologist and Associate Professor of Medicine Dr. William H. Fissell IV, is making major progress on a first-of-its kind device to free kidney patients from dialysis. He is building an implantable artificial kidney with microchip filters and living kidney cells that will be powered by a patient’s own heart.
“We are creating a bio-hybrid device that can mimic a kidney to remove enough waste products, salt and water to keep a patient off dialysis,” said Fissell.
Fissell says the goal is to make it small enough, roughly the size of a soda can, to be implanted inside a patient’s body.
The key to the device is a microchip.
“It’s called silicon nanotechnology. It uses the same processes that were developed by the microelectronics industry for computers,” said Fissell.
The chips are affordable, precise and make ideal filters. Fissell and his team are designing each pore in the filter one by one based on what they want that pore to do. Each device will hold roughly fifteen microchips layered on top of each other.
But the microchips have another essential role beyond filtering.
“They’re also the scaffold in which living kidney cells will rest,” said Fissell.
Fissell and his team use live kidney cells that will grow on and around the microchip filters. The goal is for these cells to mimic the natural actions of the kidney.
“We can leverage Mother Nature’s 60 million years of research and development and use kidney cells that fortunately for us grow well in the lab dish, and grow them into a bioreactor of living cells that will be the only ‘Santa Claus’ membrane in the world: the only membrane that will know which chemicals have been naughty and which have been nice. Then they can reabsorb the nutrients your body needs and discard the wastes your body desperately wants to get rid of,” said Fissell.
Because this bio-hybrid device sits out of reach from the body’s immune response, it is protected from rejection.
“The issue is not one of immune compliance, of matching, like it is with an organ transplant,” said Fissell.
The device operates naturally with a patient’s blood flow.
“Our challenge is to take blood in a blood vessel and push it through the device. We must transform that unsteady pulsating blood flow in the arteries and move it through an artificial device without clotting or damage.”
And that’s where Vanderbilt biomedical engineer Amanda Buck comes in. Buck is using fluid dynamics to see if there are certain regions in the device that might cause clotting.
“It’s fun to go in and work in a field that I love, fluid mechanics, and get to see it help somebody,” said Buck.
Vanderbilt biomedical engineer Amanda Buck is using fluid dynamics to see if there are certain regions in the device that might cause clotting.
Fissell says he has a long list of dialysis patients eager to join a future human trial. Pilot studies of the silicon filters could start in patients by the end of 2017.
The Latest on: Artificial Kidney
via Google News
The Latest on: Artificial Kidney
- VEON's Beeline to bring mobile AI to health careon August 23, 2021 at 7:34 am
Beeline is teaming up with Sechenov Medical University to rapidly diagnose diseases and conditions in traumatology and histology. Beeline is a subsidiary of telecommunications firm VEON. Per reports, ...
- Insilico Medicine uses AI to uncover preclinical candidate for kidney fibrosison August 23, 2021 at 7:15 am
The drug discovery company reportedly used AI-powered drug discovery to come up with a promising preclinical candidate for treatment of the kidney ailment.
- VEON's Beeline to bring mobile AI technology to medical diagnosis and researchon August 22, 2021 at 11:01 pm
VEON Ltd. (NASDAQ: VEON) (Amsterdam: VEON), a leading global provider of connectivity and internet services, announces that its mobile operator in Russia, Beeline, is collaborating with Russia's ...
- Vital Organs Support Systems and Medical Bionics Market Estimated to Grow at a CAGR of 6.2% During the Forecast Period 2021-2026on August 20, 2021 at 6:45 pm
Vital Organs Support Systems And Medical Bionics Market” Factors Such as Rise in Geriatric Population, Scarcity of Donor Organs Are Amongst the Major ...
- Dosis Expands Kidney Care Platform With Iron Advisor Tool To Personalize Anemia Managementon August 19, 2021 at 6:05 am
Dosis, a market leader in artificial intelligence-powered precision dosing, today announced the expansion of its kidney care platform with the release of its Strategic Iron Advisor (SIA). It is being ...
- India Artificial Organs And Bionics Market 2021 Insights and Precise Outlook - Abiomed Inc, Asahi Kasei Medical Co. Ltd, Baxter International Inc.on August 18, 2021 at 11:42 pm
India Artificial Organs And Bionics Market - Growth, Trends, And Forecast (2020 - 2025) Artificial Organs And Bionics Marke ...
- Medical Kidney Dialysis Machines Market Outlook 2021-2027: Top Companies, Trends and Future Prospects Details for Business Developmenton August 18, 2021 at 11:20 pm
Final Report will add the analysis of the impact of COVID-19 on this industry.” “Medical Kidney Dialysis Machines ...
- Artificial pancreas tested for patients with Type-2 diabeteson August 16, 2021 at 12:25 pm
Researchers had previously developed an artificial pancreas with the aim of replacing insulin injections for patients living with Type-1 diabetes An artificial pancreas could soon help people living ...
- 3 MUST KNOW NUTRITIONAL TIPS FOR KIDNEY DISEASE SUFFERERSon August 13, 2021 at 7:51 pm
Robert Galarowicz, Naturopath and Nutrition Expert zeroes in on 3 vital things Kidney Disease Sufferers need to know for food health & ...
- Artificial Organ & Bionics Market Giants Spending Is Going To Boom | Thoratec, Gambro, Berlin Heart, Cochlearon August 11, 2021 at 1:19 pm
The latest study released on the Global Artificial Organ & Bionics Market by AMA Research evaluates market size, trend, and forecast to 2026. The Artificial Organ & Bionics market study covers ...
via Bing News